Kellen Winden was chosen as a William Randolph Hearst Fund Awardee by the Harvard Medical School. The award “is intended to support research in the area of pre- and peri-natal medicine, on factors important for the prevention of neuromotor disabilities, and on the fundamental neurobiological mechanisms that underlie health and disease during the process of development.” He will be investigating the role of Fragile X protein FMRP in the pathogenesis of Tuberous SclerosiCIs.